Muro K, Feinstein T, Baranda J, Bonta I, et al. Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 study. Eur J Cancer 2025;227:115603.
PMID: 40819431